Veristat Congratulates Origin Biosciences for FDA Approval of Nulibry During the Week of Rare Disease Day 2021

Veristat Supported the NDA and Celebrates This Milestone Achievement for Children and Their Families Fighting This Rare Disease SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--#rarediseaseday--Veristat, a scientific-minded, global clinical research organization...

Full "IntellAsia: Resources" article